Access to transplant

Your patients should have access to the cell therapies they need to treat their disease—whether those therapies are transplant or new cell or gene therapies.

• Patient assistance grant program
  Explore information on patient assistance grants to help remove financial barriers before and after treatment.
• Patient support and resources
  Access our free patient support programs, education and resources to help your patients learn about and plan for treatment and recovery.
• Jason Carter Clinical Trials Search and Support (CTSS)
  Learn how the CTSS program can help you find appropriate clinical trials for your patients.
• Related Donor Services
  Discover how Related Donor Services provides solutions to travel, logistical and financial barriers to donation when your patient’s donor is a relative.
• NMDP^SM HLA Today
  Understand how HLA Today can help improve referral timing and outcomes for patients by providing your referring hematologists/oncologists with HLA typing and preliminary donor search results as early as possible after diagnosis.
• NMDP Registry^SM recruitment and availability
  Explore the initiatives underway to develop a more effective registry for our transplant center partners. Our goal is to recruit younger and more ethnically diverse donors who will be available when you need them.
• NMDP BioTherapies^SM
  Learn how through NMDP BioTherapies, we’re supporting companies developing and delivering next-generation cell therapies to accelerate patient access to treatment.

NMDP and the American Society for Transplantation and Cellular Therapy® (ASTCT) partnered to offer a dedicated resource hub that supports health care professionals navigating the complexities of transplant and cell therapy coding and billing.

The resources are appropriate whether you're new to the field or have years of experience. The hub provides answers to frequently asked questions, access to a Medicare 101 course, a CAR-T therapy coding and billing guide, and more.

The ACCESS Initiative is taking aim at patient access and outcomes inequities in transplant and cell therapy. To create meaningful, sustained change, we must have active, sustained engagement from across the transplant and cell therapy ecosystem.

Discover how you can get involved in the ACCESS Initiative and make a difference for patients.